COCRYSTAL PHARMA, INC. Cash and Restricted Cash
COCRYSTAL PHARMA, INC. (COCP) had Cash and Restricted Cash of $13.10 million as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2024-11-13
- 2024-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $13.10M.
- 2021-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $58.76M.
- 2018-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.71M.
- 2018-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.87M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2024-09-30 | $13.10M 10-Q · filed 2024-11-13 |
| 2021-12-31 | $58.76M 10-K · filed 2022-03-23 |
| 2018-09-30 | $4.71M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $6.87M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.28M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $777.00K 10-Q · filed 2018-11-09 |
| 2017-09-30 | $1.34M 10-Q · filed 2018-11-09 |
| 2017-06-30 | $3.45M 10-Q · filed 2018-08-09 |
| 2017-03-31 | $1.55M 10-Q · filed 2018-05-10 |
| 2016-12-31 | $3.64M 10-Q · filed 2018-11-09 |
| 2015-12-31 | $9.28M 10-K · filed 2018-03-21 |
| 2014-12-31 | $3.97M 10-K · filed 2018-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |